TrialDiabetologia2013

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.

F J Lavalle-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.